{
  "id": 18735750,
  "title": "Heart researchers unpack neutral findings from ZEUS, an anti-inflammatory clinical trial",
  "url": "https://urgent.news/2026/11/07/heart-researchers-unpack-neutral-findings-from-zeus-an-anti",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-07T14:40:02.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-11-heart-neutral-zeus-anti-inflammatory.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "Like cholesterol, inflammation causally contributes to the risk of cardiovascular disease, but findings from the clinical trial ZEUS indicate that the road to targeting inflammation may be less straightforward than once thought. ZEUS, a global phase 3 clinical trial led by Mass General Brigham researcher Paul Ridker, M.D., tested a drug that targets interleukin-6 (IL-6), a downstream inflammatory…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}